225 related articles for article (PubMed ID: 15128810)
21. Hybridoma cells producing antibodies against A-chain of mistletoe lectin I are resistant to this toxin.
Tonevitsky AG; Shamshiev AT; Prokoph'ev SA; Agapov II; Toptygin AYu
Immunol Lett; 1995 May; 46(1-2):5-8. PubMed ID: 7590928
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal antibody, mAb 4C13, an effective detoxicant antibody against ricin poisoning.
Dong N; Luo L; Wu J; Jia P; Li Q; Wang Y; Gao Z; Peng H; Lv M; Huang C; Feng J; Li H; Shan J; Han G; Shen B
Vaccine; 2015 Jul; 33(32):3836-42. PubMed ID: 26141013
[TBL] [Abstract][Full Text] [Related]
23. A novel neutralizing monoclonal antibody against both ricin toxin A and ricin toxin B, and application of a rapid sandwich enzyme-linked immunosorbent assay.
Guo J; Shen B; Sun Y; Yu M; Hu M
Hybridoma (Larchmt); 2006 Aug; 25(4):225-9. PubMed ID: 16934019
[TBL] [Abstract][Full Text] [Related]
24. Oropharyngeal aspiration of ricin as a lung challenge model for evaluation of the therapeutic index of antibodies against ricin A-chain for post-exposure treatment.
Pratt TS; Pincus SH; Hale ML; Moreira AL; Roy CJ; Tchou-Wong KM
Exp Lung Res; 2007; 33(8-9):459-81. PubMed ID: 17994372
[TBL] [Abstract][Full Text] [Related]
25. Assessment of ligand effects in intracellular trafficking of ricin A chain using anti-ricin hybridomas.
Kornfeld SB; Leonard JE; Mullen MD; Taetle R
Cancer Res; 1991 Mar; 51(6):1689-93. PubMed ID: 1998959
[TBL] [Abstract][Full Text] [Related]
26. Comparative efficacy of two leading candidate ricin toxin a subunit vaccines in mice.
O'Hara JM; Brey RN; Mantis NJ
Clin Vaccine Immunol; 2013 Jun; 20(6):789-94. PubMed ID: 23515013
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxicity of KDEL-terminated ricin toxins correlates with distribution of the KDEL receptor in the Golgi.
Tagge E; Chandler J; Tang BL; Hong W; Willingham MC; Frankel A
J Histochem Cytochem; 1996 Feb; 44(2):159-65. PubMed ID: 8609372
[TBL] [Abstract][Full Text] [Related]
28. Protective immunity to ricin toxin conferred by antibodies against the toxin's binding subunit (RTB).
Yermakova A; Mantis NJ
Vaccine; 2011 Oct; 29(45):7925-35. PubMed ID: 21872634
[TBL] [Abstract][Full Text] [Related]
29. Monoclonal antibody-ricin A chain conjugates (immunotoxins): potential therapeutic agents for human colon carcinoma.
Gallagher WJ; Burk MW
J Surg Res; 1986 Feb; 40(2):159-66. PubMed ID: 3945071
[TBL] [Abstract][Full Text] [Related]
30. Correlation between in vivo toxicity and preclinical in vitro parameters for the immunotoxin anti-B4-blocked ricin.
Grossbard ML; Lambert JM; Goldmacher VS; Blättler WA; Nadler LM
Cancer Res; 1992 Aug; 52(15):4200-7. PubMed ID: 1379121
[TBL] [Abstract][Full Text] [Related]
31. Antibody-mediated inhibition of ricin toxin retrograde transport.
Yermakova A; Klokk TI; Cole R; Sandvig K; Mantis NJ
mBio; 2014 Apr; 5(2):e00995. PubMed ID: 24713323
[TBL] [Abstract][Full Text] [Related]
32. Molecular dissection of antibody responses against pneumococcal surface protein A: evidence for diverse DH-less heavy chain gene usage and avidity maturation.
Rohatgi S; Dutta D; Tahir S; Sehgal D
J Immunol; 2009 May; 182(9):5570-85. PubMed ID: 19380805
[TBL] [Abstract][Full Text] [Related]
33. Polyclonal anti-idiotypes induce antibody responses protective against ricin cytotoxicity.
Chanh TC; Hewetson JF
Immunology; 1993 Aug; 79(4):681-4. PubMed ID: 8406596
[TBL] [Abstract][Full Text] [Related]
34. A novel neutralizing monoclonal antibody against cell-binding polypeptide of ricin.
Guo JW; Shen BF; Feng JN; Sun YX; Yu M; Hu MR
Hybridoma (Larchmt); 2005 Oct; 24(5):263-6. PubMed ID: 16225427
[TBL] [Abstract][Full Text] [Related]
35. Quantitative profiling of the in vivo enzymatic activity of ricin reveals disparate depurination of different pulmonary cell types.
Falach R; Sapoznikov A; Gal Y; Israeli O; Leitner M; Seliger N; Ehrlich S; Kronman C; Sabo T
Toxicol Lett; 2016 Sep; 258():11-19. PubMed ID: 27298272
[TBL] [Abstract][Full Text] [Related]
36. Blockade of the galactose-binding sites of ricin by its linkage to antibody. Specific cytotoxic effects of the conjugates.
Thorpe PE; Ross WC; Brown AN; Myers CD; Cumber AJ; Foxwell BM; Forrester JT
Eur J Biochem; 1984 Apr; 140(1):63-71. PubMed ID: 6608447
[TBL] [Abstract][Full Text] [Related]
37. Novel chimeric anti-ricin antibody C4C13 with neutralizing activity against ricin toxicity.
Wang Y; Guo L; Zhao K; Chen J; Feng J; Sun Y; Li Y; Shen B
Biotechnol Lett; 2007 Dec; 29(12):1811-6. PubMed ID: 17657413
[TBL] [Abstract][Full Text] [Related]
38. Hybridoma cells containing intracellular anti-ricin antibodies show ricin meets secretory antibody before entering the cytosol.
Youle RJ; Colombatti M
J Biol Chem; 1987 Apr; 262(10):4676-82. PubMed ID: 3558362
[TBL] [Abstract][Full Text] [Related]
39. Stepwise engineering of heterodimeric single domain camelid VHH antibodies that passively protect mice from ricin toxin.
Vance DJ; Tremblay JM; Mantis NJ; Shoemaker CB
J Biol Chem; 2013 Dec; 288(51):36538-47. PubMed ID: 24202178
[TBL] [Abstract][Full Text] [Related]
40. Identification and characterization of a monoclonal antibody that neutralizes ricin toxicity in vitro and in vivo.
Lemley PV; Amanatides P; Wright DC
Hybridoma; 1994 Oct; 13(5):417-21. PubMed ID: 7860097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
